Ida Steinberger

Title: Ida Steinberger: Innovator in Chimeric Protein Research

Introduction

Ida Steinberger is a notable inventor based in Jerusalem, Israel. She has made significant contributions to the field of biotechnology, particularly in the development of chimeric proteins. Her work focuses on innovative solutions for treating autoimmune diseases, including multiple sclerosis.

Latest Patents

Ida Steinberger holds a patent for "Pseudomonas exotoxin-myelin basic protein chimeric proteins." This invention involves a chimeric protein that comprises an exotoxin moiety linked to a myelin basic protein moiety. The myelin basic protein moiety is selected from various groups, including specific amino acid sequences from guinea-pig and human myelin basic proteins. The chimeric protein is designed to be useful in treating autoimmune diseases, especially multiple sclerosis.

Career Highlights

Steinberger is associated with Yissum Research Development Company of the Hebrew University of Jerusalem Ltd. Her work at this institution has allowed her to explore groundbreaking research in the field of immunology and protein engineering.

Collaborations

Ida has collaborated with esteemed colleagues, including Haya Lorberboum-Galski and Eveline Beraud. These partnerships have further enhanced her research and contributed to the advancement of her innovative projects.

Conclusion

Ida Steinberger's contributions to the field of chimeric proteins represent a significant advancement in the treatment of autoimmune diseases. Her innovative research continues to pave the way for new therapeutic approaches.